Effect of immunomodulatory therapy and other factors on employment loss time in multiple sclerosisM J Lage
HealthMetrics Outcomes Research, Groton, CT, USA
Work 27:143-51. 2006
..24 fewer days, P<0.03), worker's compensation (29.50 fewer days, P<0.04) or any reason (53.70 fewer days, P< 0.003)...
Outcomes and costs of patients with persistent asthma treated with beclomethasone dipropionate hydrofluoroalkane or fluticasone propionateMaureen J Lage
HealthMetrics Outcomes Research, 120 Anchorage Circle, Groton, CT 06340, USA
Adv Ther 26:762-75. 2009
..Examine outcomes and costs of patients with persistent asthma who initiated treatment with beclomethasone dipropionate hydrofluoroalkane (BDP-HFA) or fluticasone propionate (FP)...
- Healthcare costs in postmenopausal women with hormone-positive metastatic breast cancer
Maureen J Lage
HealthMetrics Outcomes Research, Groton, CT 06340, USA
J Med Econ 13:691-7. 2010
..This study examines costs for postmenopausal women with hormone receptor positive (HR+) metastatic breast cancer (mBC)...
The relationship between antipsychotic medication adherence and patient outcomes among individuals diagnosed with bipolar disorder: a retrospective studyMaureen J Lage
Health Metrics Outcomes Research, Groton, CT, USA
Ann Gen Psychiatry 8:7. 2009
..This observational study examined the association between adherence to antipsychotics and risk of hospitalizations and emergency room (ER) visits among patients with bipolar disorder...
- Comparison of costs among patients with type 2 diabetes treated with exenatide or sitagliptin therapy
Maureen J Lage
HealthMetrics Outcomes Research LLC, 120 Anchorage Circle, Groton, Connecticut 06340, USA
Adv Ther 26:217-29. 2009
..The purpose of this analysis was to compare costs among patients with type 2 diabetes (T2D) treated with either of these agents...
- The cost of treating skeletal-related events in patients with prostate cancer
Maureen J Lage
HealthMetrics Outcomes Research, LLC, 120 Anchorage Cir, Groton CT 06340, USA
Am J Manag Care 14:317-22. 2008
..To examine the economic burden of skeletal-related events (SREs) and to assess the frequency of different types of SREs in this population...
- Association between androgen-deprivation therapy and incidence of diabetes among males with prostate cancer
M J Lage
HealthMetrics Outcomes Research, LLC, Groton, Connecticut, USA
Urology 70:1104-8. 2007
..Given that metabolic syndrome is related to diabetes, this research examined whether use of ADT was associated with an increase in the incidence of diabetes...
- Costs and resource use of mild persistent asthma patients initiated on controller therapy
Gene L Colice
The George Washington University School of Medicine and Washington Hospital Center, Washington, DC, USA
J Asthma 45:293-9. 2008
..The treatment of mild persistent asthma is controversial...
- Trends in the prescription of antidiabetic medications in France: evidence from primary care physicians
Kristina Secnik Boyc
Eli Lilly and Company, Indianapolis, Indiana, USA
Adv Ther 24:803-13. 2007
..05). In France, antidiabetic medication prescribing patterns changed from 2001 to 2003. In general, the trend has been away from sulfonylurea monotherapy and toward metformin monotherapy, insulin monotherapy, or combination therapy...
- The cost of treating anxiety: the medical and demographic correlates that impact total medical costs
Martin D Marciniak
Lilly Research Laboratories, Indianapolis, IN, USA
Depress Anxiety 21:178-84. 2005
....
- Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial
Baojin Zhu
Lilly Research Laboratories, Indianapolis, IN, USA
Curr Med Res Opin 21:555-64. 2005
....
- Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder
Kristina Secnik
Lilly Research Laboratories, Indianapolis, Indiana, USA
Pharmacoeconomics 23:93-102. 2005
..These findings suggest that there may be an opportunity for the effective treatment of ADHD to lead to cost-offsets...
- The medical costs of migraine and comorbid anxiety and depression
Jacqueline Pesa
Health Economics and Outcomes Research, AstraZeneca, Willmington, DE, USA
Headache 44:562-70. 2004
..This study also suggests that clinicians should be aware that while proper treatment of migraine with effective acute and prophylactic therapy is important, attention must also be directed to comorbid conditions...
- Medical and productivity costs of anxiety disorders: case control study
Martin Marciniak
Lilly Research Laboratories, Indianapolis, Indiana, USA
Depress Anxiety 19:112-20. 2004
..Results indicate that anxiety disorders are associated with significant medical and productivity costs...
- Olanzapine versus risperidone in the treatment of schizophrenia : a comparison of costs among Texas Medicaid recipients
Karen L Rascati
College of Pharmacy, The University of Texas at Austin, Austin, Texas, USA
Pharmacoeconomics 21:683-97. 2003
....
